Objective-Cigarette smoke exposure (CSE) is a risk factor for cerebral aneurysm (CA) formation, but the molecular mechanisms are unclear. Although CSE is known to contribute to excess reactive oxygen species generation, the role of oxidative stress on vascular smooth muscle cell (VSMC) phenotypic modulation and pathogenesis of CAs is unknown. The goal of this study was to investigate whether CSE activates a NOX (NADPH oxidase)-dependent pathway leading to VSMC phenotypic modulation and CA formation and rupture. Approach and Results-In cultured cerebral VSMCs, CSE increased expression of NOX1 and reactive oxygen species which preceded upregulation of proinflammatory/matrix remodeling genes (MCP-1, MMPs [matrix metalloproteinase], TNF-α, IL-1β, NF-κB, KLF4 [Kruppel-like factor 4]) and downregulation of contractile genes (SM-α-actin [smooth muscle α actin], SM-22α [smooth muscle 22α], SM-MHC [smooth muscle myosin heavy chain]) and myocardin. Inhibition of reactive oxygen species production and knockdown of NOX1 with siRNA or antisense decreased CSE-induced upregulation of NOX1 and inflammatory genes and downregulation of VSMC contractile genes and myocardin. p47phox −/− NOX knockout mice, or pretreatment with the NOX inhibitor, apocynin, significantly decreased CA formation and rupture compared with controls. NOX1 protein and mRNA expression were similar in p47phox −/− mice and those pretreated with apocynin but were elevated in unruptured and ruptured CAs. CSE increased CA formation and rupture, which was diminished with apocynin pretreatment. Similarly, NOX1 protein and mRNA and reactive oxygen species were elevated by CSE, and in unruptured and ruptured CAs. Conclusions-CSE initiates oxidative stress-induced phenotypic modulation of VSMCs and CA formation and rupture.
C igarette smoke exposure (CSE) is a major risk factor for cerebral vascular injury, including atherosclerosis, 1-5 a key process underlying cerebral aneurysm (CA) formation. [6] [7] [8] [9] [10] In addition, CSE is the most significant modifiable risk factor associated with CA formation, progression, and rupture. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] Although CSE has been demonstrated to cause significant alterations in the cerebral immune system and inflammatory response, [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] the means by which CSE contributes to the pathogenesis of CAs has not been elucidated.
In vitro and in vivo studies have shown that CSE results in endothelial dysfunction in nearly every vascular territory. [27] [28] [29] [30] [31] [32] This may be secondary to activation of immune cells, upregulation of proinflammatory mediators, and production of reactive oxygen species (ROS). 27 The key mechanisms which lead to CSE-induced vascular dysfunction remain unclear.
Unlike terminally differentiated cardiac or skeletal muscle cells, vascular smooth muscle cells (VSMCs) retain remarkable plasticity. 36, 37 In response to environmental stimuli, VSMCs can undergo changes from cells principally concerned with contraction to cells that are primarily involved in inflammation and matrix remodeling. 36 This phenotypic modulation is defined by decreased expression of key VSMC contractile proteins (SM-MHC [smooth muscle myosin heavy chain], SM-α-actin [smooth muscle α actin], and SM-22α [smooth muscle 22α]) with concomitant increased expression of inflammatory mediators. 7, 36, [38] [39] [40] [41] [42] VSMC phenotypic modulation is known to be important in the response to vascular injury 41 and the development and progression of atherosclerosis, 42 both critical processes behind CA pathogenesis. 7 Although a role has been postulated for the significant pathological effects of CSE, studies have not assessed its role in VSMC phenotypic modulation or the mechanisms directly contributing to CA formation, progression, or rupture. Therefore, the aims of the present study are (1) to evaluate the effect of CSE in inducing phenotypic modulation of cultured cerebral VSMCs through a NOX (NADPH oxidase)-dependent pathway; (2) to assess in vivo whether phenotypic modulation of cerebral VSMCs during CA formation is accompanied by increased free radical generation and oxidative stress; (3) to determine whether CSE further increases oxidative stress along with downregulation of VSMC marker genes and upregulation of inflammatory genes during CA formation and rupture; and (4) to assess whether CSE-induced oxidative stress leads to increased CA formation and rupture and whether genetic and pharmacological inhibitions of NOX reverse CSE initiation of oxidative stress, induction of phenotypic modulation, and CA formation and rupture.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Statistical Analysis
Power analysis is given in Materials and Methods in the online-only Data Supplement. All experiments were performed with a minimum of triplicate samples and were conducted in 3 to 6 independent experiments unless otherwise indicated. Data are presented as mean and range for continuous variables and as frequency for categorical variables. Analysis was performed using χ 2 , Fisher exact, Wilcoxon rank-sum, and Kruskal-Wallis tests with Wilcoxon rank-sum post hoc test as appropriate. Secondary assessment of risk of rupture was performed by Kaplan-Meier survival analysis with Cox regression analysis to assess hazard ratios. Error bars represent SEM. Statistical significance was considered defined as P<0.05.
Results

CSE-Induced Expression of NOX and Oxidative Stress in VSMC
As cigarette smoke has been shown to increase inflammation and ROS levels in VSMCs, 27 we sought to determine the role of CSE on NOX expression and on the phenotypic modulation of cultured cerebral VSMCs. VSMC were treated with either 10 or 40 μg/mL CSE for up to 48 hours. CSE increased expression of NOX1 mRNA in a dose-and time-dependent fashion with maximal expression occurring 4 hours after exposure followed by a gradual decrease in expression over time ( Figure 1A ). In contrast, NOX2, NOX3, and NOX4 expression were not significantly changed by CSE ( Figure 1B through 1D ). To assess if CSE was inducing oxidative stress, we exposed VSMC to 10 or 40 μg/mL CSE and ROS levels were measured for up to 48 hours after CSE using lucigenin chemiluminescence as described in the Methods. As shown in Figure 1E , ROS levels were increased significantly 30 minutes after CSE, and they continued to increase reaching maximal levels of ≈5-fold of controls by 4 hours which was followed by a gradual decease in ROS levels reaching ≈2-fold of controls at 48 hours ( Figure 1E ). Similarly, in situ superoxide imaging of VSMC with dihydroethidium demonstrated an increase in free radical expression following CSE ( Figure 1F ).
CSE Induces a Proinflammatory and Matrix Remodeling Phenotypic Modulation of VSMC
To determine if CSE altered the gene expression profile of VSMC, we exposed VSMC to CSE for 24 hours and measured gene expression by RT-PCR (real-time polymerase chain reaction; Table) . CSE significantly increased expression of the proinflammatory and matrix remodeling genes MCP-1, MMP-3 (matrix metalloproteinase), MMP-9, TNF-α, IL-1β, iNOS, NF-κB, and KLF4 (Kruppel-like factor 4; Figure 2 ). Gene expression was generally maximal at 24 hours, at a time point after maximal NOX1 expression. In addition, pretreatment with the antioxidant enzyme, SOD (superoxide dismutase), abrogated CSE-induced upregulation of proinflammatory and matrix remodeling genes ( Figure 2A ).
CSE Repressed Myocardin and Phenotypic Marker Gene Expression in VSMC
Although many factors control VSMC differentiation, myocardin has been shown to be a key transcriptional regulator of SMC differentiation in peripheral vascular beds. 36 To assess the effects of CSE on phenotypic modulation, we exposed VSMC to CSE and analyzed expression of VSMC marker genes by RT-PCR. CSE significantly reduced expression of myocardin mRNA with a maximal suppression at 24 hours ( Figure 2B ). Similarly, CSE significantly downregulated SM-α-actin, SM-MHC, and SM-22α mRNA expression ( Figure 2B ). CSE-dependent suppression of myocardin and SMC marker gene expression was prevented by pretreatment with SOD ( Figure 2B ).
NOX1 Decreases Promoter Activity and Expression of VSMC Marker Genes
Our data indicate that the phenotypic modulation of VSMC by CSE is dependent on oxidative stress. Because we show in Figure 1 that NOX1, an inducer of oxidative stress, is upregulated early after CSE, we were interested in determining whether NOX1 regulates VSMC gene expression. To assess the role of NOX1 on the expression of VSMC marker genes, VSMCs were cotransfected with VSMC promoter-reporter constructs and with a NOX1 expression vector. Overexpression of NOX1 significantly decreased SM-α-actin and SM-MHC promoter activity ( Figure 2C ). The reduced promotor activity in NOX1-overexpressing VSMC was paralleled with a significant reduction in endogenous gene expression of SM-α-actin, SM-22α, SM-MHC, and myocardin levels ( Figure 2D) . Similarly, overexpression of NOX1 significantly increased expression of proinflammatory and matrix remodeling genes (KLF4, MCP-1 MMP-2, MMP-3, MMP-9, IL-1β, NF-κB, iNOS; Figure 2E ). To determine if NOX1 is involved in CSE-mediated VSMC gene expression, we knocked down NOX1 protein expression by adenovirus-delivered antisense NOX1 and analyzed CSE changes in gene expression. As demonstrated in Figure 2F , when cells were infected with control antisense and CSE, there was a significant decrease in myocardin and SM-MHC and an increase in MCP-1 and KLF4 expression. In contrast, knockdown of NOX1 reversed CSE-induced decrease of myocardin and SMC-MHC and increase of MCP-1 and KLF4 ( Figure 2F ). To confirm a role of NOX1 in CSE gene regulation, cultured VSMC were transfected with siRNA specific to NOX1 or GFP (green fluorescent protein) for 24 hours followed by treatment with CSE (40 µg/mL) for 24 hours. CSE treatment significantly increased the expression of NOX1, KLF4, IL-1β, and VCAM when treated with control (siGFP), but not when cells were treated with CSE-and NOX1-specific siRNA ( Figure 2G ).
CA Formation
CA formation was performed as previously described. 43 On the basis of dose assessment, experimental planning, and power analysis, mice were injected with vehicle (n=10) or a single stereotactic elastase injection (3.5 mU, n=10; 17.5 mU, n=10; and 35 mU, n=10) and aneurysm formation, defined as 1.5× the diameter of the parent vessel, determined 28 days later. CAs were not observed in sham-treated animals but were formed in a dose-dependent fashion with 10%, 55%, and 80% of animals developing aneurysm formation, respectively ( Figure 3A ).
Role of NOX in the Formation of CAs
On the basis of our results and other published data, 44 we sought to assess the role of NOX in CA formation in vivo. To test the role of NOX in CA formation, animals began treatment with the NOX inhibitor apocynin 3 days before elastase injection and were compared with CA formation in vehicle-treated mice and p47phox −/− mice, which lack NOX activity. Mice pre-treated with apocynin, p47phox −/− mice, and those treated only with vehicle undergoing CA induction had significant increases in systolic blood pressure 7 days after elastase injection (35 mU) that was sustained until 28 days, but was not significantly different between the 3 cohorts at any time point ( Figure 3B ).
Analysis of CA formation revealed aneurysm formation in 21 of 25 animals (84%) receiving 35 mU of elastase and vehicle when compared with 8 of 25 animals (32%, P<0.001) treated with apocynin ( Figure 3C ). The incidence of ruptured aneurysm was also significantly increased in vehicle-treated mice, 15 of 25 (60%), compared with those receiving apocynin (3 of 25, 12%, P=0.001; Figure 3C ). CA formation was associated with the development of neurological deficits (score 1-5) and aneurysmal subarachnoid hemorrhage between days 7 and 21. Survival analysis demonstrated that animals treated with apocynin were 7.2× (95% confidence interval, 2.1-25.3; P=0.002) less likely to have CA rupture compared with those receiving vehicle. Next, we induced CA formation in p47phox −/− mice, which lack NOX activity. When compared with wild-type mice, p47phox −/− mice were significantly less likely to form CAs (2 of 12; 16.7%; P=0.001; Figure 3C ) and had a lower incidence of CA rupture (1 of 12; 8.3%; P=0.004; Figure 3C ). Similarly, survival analysis demonstrated that p47phox −/− mice were also less likely to experience CA rupture (hazard ratio, 10.3; 95% confidence interval, 1.4-78.2; P=0.024). As the incidence of CA formation and rupture was low in p47phox −/− mice, these experiments were aborted after the first cohort of 12 mice. These results suggest that NOX plays an important role in CA formation.
NOX Expression in Unruptured and Ruptured Intracranial Aneurysms
Histological assessment of the CAs demonstrated structural changes that were similar to those found in human CAs ( Figure 4 , an enlarged image is shown in Figure I in the online-only Data Supplement). 45, 46 Hematoxylin and eosin and trichrome staining of cerebral vessels from sham-operated mice demonstrated 2 to 3 layers of SMCs and a single layer of continuous endothelial cells ( Figure 4A1 When compared with sham mice, there was no difference in immunofluorescence reactivity for NOX1 in p47phox −/− mice or those treated with apocynin (not shown). NOX1 immunoreactivity was significantly higher in unruptured CAs, and highest in ruptured CAs ( Figure 4B3 and 4B4, 4C3, and 4C4). Next, we sought to determine the cellular source of NOX1. To localize NOX1 expression, samples were costained with either SMC-22α for SMCs or CD68 for macrophages and NOX1 (Figure 4 ). NOX1 expression was observed to colocalize with both SMCs and macrophages in both unruptured ( Figure 4B3 and 4B4) and ruptured CAs ( Figure 4C3 and 4C4) . SM-22α but not CD68 was observed in normal-sized cerebral blood vessels adjacent to CAs ( Figure 4C3 ). There were more macrophages observed in ruptured CAs ( Figure 4C4 ) when compared with unruptured CAs (Figure 4B4) , and an absence of macrophages in sham-operated mice ( Figure 4A4 ).
To assess whether an increase in NOX1 expression leads to increased oxidative stress during CA formation, we measured superoxide production with dihydroethidium as described in Methods. As shown in Figure 4A5 , there was a low level of free radical formation observed in sham-operated mice. In contrast, free radical expression was increased in unruptured CAs ( Figure 4B5 ) and further increased in ruptured CAs ( Figure 4C5 ) when compared with sham-operated mice ( Figure 4A5 ). There was limited expression of free radicals in p47phox −/− mice or those treated with apocynin (not shown), suggesting a possible connection between NOX1 expression and free radical production in CA formation. Cigarette smoke exposure (CSE) induces proinflammatory and matrix remodeling phenotypic modulation of VSMCs and represses myocardin and smooth muscle cell (SMC) marker gene expression. Cultured cerebral VSMCs were treated for 24 h with the indicated concentration of CSE with or without SOD (superoxide dismutase) pretreatment. Real-time polymerase chain reaction (RT-PCR) was performed, normalized to 18S rRNA, and expressed as fold increase over vehicle. Proinflammatory and matrix remodeling gene expression is shown in A with myocardin and SMC marker gene expression shown in B. *P<0.05 vs control (vehicle) using Kruskal-Wallis analysis with Wilcoxon rank-sum post hoc test. C, SM-MHC (smooth muscle myosin heavy chain) and SM-α-actin (smooth muscle α actin) promoterluciferase constructs were transiently transfected into cerebral VSMCs for 24 h followed by overexpression of NOX1 (NADPH oxidase 1) with adenovirus for 24 h. Luciferase activity was measured and normalized to total protein content and then expressed as fold increase over control (empty adenovirus). *P<0.05 vs control using Wilcoxon rank sum. The effects of NOX1 overexpression on SMC marker gene (myocardin, SM-22α [smooth muscle 22α], SM-α-actin, and SM-MHC) expression is shown in D with proinflammatory and matrix remodeling genes expression levels shown in E. All RT-PCR data were normalized to 18S rRNA and expressed as fold increase over control (empty adenovirus). *P<0.05 vs control using Wilcoxon rank sum. F, Cultured VSMC was treated with CSE (40 µg/mL) and infected with NOX1 adenovirus (Ad) or antisense NOX1 adenovirus (AS) for 24 h. RT-PCR was performed to measure the mRNA expression levels of myocardin and the SMC marker gene, SM-MHC and the proinflammatory and matrix remodeling genes KLF4 (Kruppel-like factor 4) and MCP-1 which were normalized to 18S rRNA and expressed as fold increase over control (empty adenovirus). *P<0.05 vs control using Kruskal-Wallis analysis with Wilcoxon rank-sum post hoc test. G, Cultured VSMC were transfected with siRNA specific to NOX1 or siNeg (GFP [green fluorescent protein]) and treated with CSE (40 µg/mL) for 24 h. mRNA expression of indicated genes were analyzed with RT-PCR and normalized to 18S rRNA. *P<0.05 vs siNeg+Vehicle using Kruskal-Wallis analysis with Wilcoxon rank-sum post hoc test. For all experiments, values represent mean±SEM of n=3 to 6. APO indicates apocynin; A.U., arbitrary unit; and MOI, multiplicity of infection.
To confirm that NOX1 is expressed during CA formation, we analyzed NOX1 expression by RT-PCR. When compared with sham-operated mice, RT-PCR analysis demonstrated no significant difference in NOX1 mRNA expression in cerebral blood vessels from p47phox −/− mice or those treated with apocynin ( Figure 4D ). NOX1 mRNA extracted from unruptured, and even more so from ruptured CAs, was significantly elevated when compared with sham-operated mice. NOX2, NOX3, and NOX4 expression were not significantly changed in the various cohorts ( Figure 4E through 4G) . As a secondary control, β-actin expression was assessed and found not to be significantly different among sham-operated mice, p47phox −/− mice, or those treated with apocynin, unruptured aneurysm, and ruptured CAs (data not shown).
NOX Regulates SMC Phenotypic Modulation in Unruptured and Ruptured CAs
Our in vitro VSMC studies reveal a NOX1-dependent regulation of VSMC phenotypic gene expression. Therefore, we were interested in determining whether NOX also regulated VSMC gene expression, in vivo. To test this possibility we first assessed whether VSMC phenotypic modulations occur in our CA model system, by examining alterations in expression of VSMC marker genes and proinflammatory and matrix remodeling genes. As shown in Figure 4H , SM-α-actin, SM-MHC, and SM-22α mRNA levels were decreased in ruptured CAs when compared to unruptured CAs. When compared with both unruptured and ruptured CAs, sham-operated mice, p47phox −/− mice, and those treated with apocynin had significantly higher levels of VSMC marker genes ( Figure 4H ). In addition, myocardin was decreased in unruptured CAs and further decreased in ruptured CAs ( Figure 4H ). Similar to our in vitro gene expression studies, we found that the proinflammatory and matrix remodeling genes, MCP-1, MMP-3, MMP-9, TNF-α, IL-1β, iNOS, TNF-α, NF-κB, VCAM, and KLF4, were increased in unruptured CAs and further increased in ruptured CAs ( Figure 4I ).
The Role of CSE in CA Formation and Rupture
To assess the effects of CSE in CA development and rupture, mice underwent daily CSE for 7 days before nephrectomy. Mice then underwent CA induction surgery (3.5 mU elastase) as described in the Methods. Vehicle control mice and mice exposed to CSE and CSE+apocynin pretreatment had significant increases in systolic blood pressure 7 days after elastase injection that was sustained until day 28, but was not significantly different between the 3 cohorts at any time point ( Figure 5A ). Analysis of CA formation revealed that the incidence of CA formation was significantly higher in mice receiving CSE (13 of 30; 43.3%) when compared with mice receiving CSE with pretreatment of apocynin (6 of 30; 20%), or control mice not receiving CSE (3 of 30; 10%; P=0.011, Figure 5B) . Similarly, the rate of CA rupture was also significantly increased in mice receiving CSE alone (9 of 30; 30%) versus those receiving CSE, but pretreated with apocynin (2 of 30; 6.7%) and control mice that did not receive CSE (0 of 30; 0%; P=0.001; Figure 5B ). CA formation was not observed in animals receiving CSE and undergoing sham surgery (data not shown).
Because CSE enhances both CA formation and rupture, we were then interested in determining whether CSE altered NOX1 expression in both unruptured and ruptured CAs. Therefore, we assessed NOX1 mRNA levels after CA induction. As demonstrated in Figure 5C , RT-PCR analysis revealed that CSE increased expression of NOX1 in unruptured CAs, which was further increased in ruptured CA. In contrast, there was no change in NOX2, NOX3, or NOX4 expression in any of the cohorts (Figure 5D through 5F ). The elevated expression of NOX1 in CA of CSE-treated mice was also increased over animals that underwent sham surgery but received CSE and furthermore over a control cohort that underwent sham surgery but did not receive CSE or a cohort undergoing surgery with CSE but pretreated with apocynin. The increase in NOX1 expression in CA after CSE was paralleled with a similar increase in superoxide production, as assessed by dihydroethidium imaging. Exposing mice to CSE alone did not substantially increase dihydroethidium fluorescence when compared with controls, whereas pretreatment with apocynin, which inhibits NOX activity, reduced the dihydroethidium fluorescence ( Figure 5G ). Superoxide production was found to be increased in unruptured and furthermore in ruptured aneurysms ( Figure 5G ; an enlarged image is shown in Figure II in the online-only Data Supplement). 
CSE Initiates NOX-Dependent VSMC Phenotypic Modulation in CA Formation and Rupture
To assess whether VSMC phenotypic modulation occurs in the formation and rupture of CAs after CSE, we assessed alterations in mRNA expression of VSMC marker genes and proinflammatory and matrix remodeling genes. SM-α-actin, SM-MHC, SM-22α mRNA, and myocardin expression were decreased in ruptured CAs when compared with unruptured CAs, and when compared with those pretreated with apocynin ( Figure 5H ). In addition, animals receiving CSE that underwent sham surgery had decreased levels of SM-α-actin, SM-MHC, and SM-22α mRNA when compared with those pretreated with apocynin or a sham surgery group that was not exposed to cigarette smoke ( Figure 5H ). Cigarette smoke exposure (CSE) increases the incidence of cerebral aneurysm (CA) formation and rupture, and NOX1 (NADPH oxidase 1) mRNA expression in vivo and induces phenotypic modulation. To assess the role of CSE in CA development and rupture, mice underwent daily CSE starting 7 days before nephrectomy followed by CA induction surgery (3.5 mU elastase) as described in Methods. The effect of CA induction on blood pressure is shown in A. *P<0.05 vs day 0 using Kruskal-Wallis analysis with Wilcoxon rank-sum post hoc test. The incidence of CA formation and rupture in animals treated with vehicle, CSE but pretreated with apocynin, and CSE alone is shown in B. The effects of CSE, apocynin, CA formation, and rupture on NOX1, NOX2, NOX3, and NOX4 mRNA expression are shown in C-F, and free radical expression is shown in G. *P<0.05 vs sham surgery controls using Kruskal-Wallis analysis with Wilcoxon rank-sum post hoc test. mRNA expression of VSMC phenotypic genes and proinflammatory, matrix remodeling genes is shown in H and I, respectively, after indicated treatments. *P<0.05 vs sham surgery controls using Kruskal-Wallis analysis with Wilcoxon rank-sum post hoc test. For all experiments, values represent mean±SEM of n=3 to 6. KLF4 indicates Kruppel-like factor 4; SM-α-actin, smooth muscle α actin; SM-22α, smooth muscle 22α; and SM-MHC, smooth muscle myosin heavy chain.
Analysis of inflammatory and matrix remodeling genes revealed increased expression of MCP-1, MMP-3, MMP-9, TNF-α, IL-1β, iNOS, TNF-α, NF-κB, VCAM, and KLF4 in unruptured CAs, which were further increased in ruptured CAs receiving CSE ( Figure 5I ). This was also increased over animals that underwent sham surgery, but received CSE and furthermore over cohorts either pretreated with apocynin or those only receiving sham surgery.
Direct Application of CSE Alters NOX1 Expression and VSMC Phenotype
To access whether CSE directly affects NOX1 expression and modulates phenotypic gene expression, in vivo, or whether other systemic factors are required, we directly applied CSE to the adventitial surface of rat carotid arteries using a pluronic gel as detailed in Methods. Consistent with our previous findings, NOX1 mRNA expression was significantly increased 6 hours after CSE application when compared with application of pluronic gel alone ( Figure 6A ). The increase in NOX1 was followed with a significant decrease in mRNA expression of the VSMC marker genes (SM-22α, SM-α-actin, and SM-MHC) and myocardin and with a parallel increase in proinflammatory and matrix remodeling genes, KLF4, MCP-1, MMP-3, MMP-9, TNF-α, and IL-1β ( Figure 6B and 6C) , 12 hours after CSE application.
Discussion
Smoking is a key modifiable risk factor for CA formation and rupture. However, the precise mechanisms of CSE-induced vascular alteration and injury in the cerebral circulation remain unclear.
11-24 CSE can cause significant alterations in the cerebral immune system and inflammatory pathways, resulting in direct vascular injury and production of ROS. [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] In addition, prior studies have found that CSE results in endothelial dysfunction, leading to attraction of proinflammatory mediators and immune cells, resulting in further SMC injury. [27] [28] [29] [30] [31] [32] As these are key mechanisms underlying CA pathogenesis, it has been hypothesized that CSE, 8 oxidative stress, 47 and SMC phenotypic modulation 48 contribute to a proinflammatory environment, 7 which promotes CA formation and rupture. In this study, we have found that NOX and oxidative stress contributes to CA formation and rupture. In addition, CSE leads to upregulation of NOX1 and free radical oxidative stress both in vitro in cultured cerebral VSMCs and in vivo in a mouse model of CA formation and rupture. Excess free radical production leads to VSMC phenotypic modulation, with alteration of VSMC function from a role primarily concerned with contraction to that of inflammation and matrix remodeling. Both pharmacological and genetic inhibition of NOX-induced oxidative stress prevented VSMC phenotypic modulation and decreaseed both CA formation and rupture. CSE increases oxidative stress and CA formation and rupture, while pharmacological inhibition of NOX is protective against CSE-induced oxidative stress, VSMC phenotypic modulation, and CA formation and rupture.
Increased ROS have been previously demonstrated in human CAs, which may arise from many potential sources. 49 In this study, we found upregulation of NOX1 and oxidative stress in an in vivo model of CA formation and rupture that involves induced hypertension. We, and others, have also found that NOX expression and ROS formation are increased in an in vivo model of CA formation that involves induced hypertension and hemodynamic stress before CA formation. 49 , 50 We also demonstrate that CSE further increases NOX1 expression and induces oxidative stress and further contributes to CA formation and rupture. Hypertension, hemodynamic stress, and CSE are significant risk factors for CA formation and rupture and likely all contribute to ROS formation. 7, 8, 47 CSE is a major potential cause of CA induction, which exerts its effects through activation of NOX and production of ROS. 51, 52 The observed effects of CSE may arise directly from the gas/tar phase, activated inflammatory cells, or endogenous sources of ROS, such as xanthine oxidase, uncoupled nitric oxide, and the mitochondrial electron transport chain. 32, 52 Once activated, VSMCs and activated macrophages can further produce ROS within CAs.
In this study, we found that CSE results in NOX-induced VSMC phenotypic modulation both in vivo and in vitro. CSEinduced NOX1 upregulation and ROS formation were followed by downregulation of VSMC marker genes. In addition, inhibition of free radical formation reversed NOX1-induced VSMC phenotypic modulation. Similarly, NOX-induced VSMC phenotypic modulation occurred in CA formation and rupture and was similarly abrogated by both genetic and pharmacological Figure 6 . Direct effects of cigarette smoke exposure (CSE) on NOX1 (NADPH oxidase 1) mRNA expression and phenotypic modulation. CSE was directly applied to the adventitial surface of rat carotid arteries using a pluronic gel containing 0.8 mg/mL CSE. Changes in NOX1 mRNA expression 6 to 8 h after direct application of CSE is shown in A. mRNA expression of vascular smooth muscle cell (VSMC) phenotypic genes and proinflammatory and matrix remodeling genes are shown in B and C, respectively, after 12 h of direct CSE application. All values represent mean±SEM of n=6. *P<0.05 vs control using Wilcoxon rank sum. KLF4 indicates Kruppel-like factor 4; SM-α-actin, smooth muscle α actin; SM-22α, smooth muscle 22α; and SM-MHC, smooth muscle myosin heavy chain.
inhibitions of NOX. In the peripheral circulation, myocardin is a key transcriptional promotor of SMC differentiation through transcriptional upregulation of SMC marker genes. 36, [38] [39] [40] Myocardin was found to be decreased both in cultured cerebral VSMCs and CAs. Results from the present experiments support that peripheral phenotypic modulation in VSMC pathology occurs through similar mechanisms within CAs.
Increased NOX1 mRNA expression was observed in both isolated VSMC and in CA tissue after CSE and was paralleled with a robust increase in NOX1 protein expression in unruptured and ruptured CA tissue. This increase in NOX1 protein levels after CA induction was primarily observed in VSMC, and to a degree, in macrophages. This is in contrast to NOX2, NOX3, and NOX4 which were not significantly increased by CSE. Our in vitro results demonstrate a link between NOX1 expression and VSM gene regulation. However, because apocynin and p47phox null mice inhibit other NOX family members besides NOX1, we cannot fully rule out the possibility that altered NOX2, NOX3, or NOX4 protein activity, and not gene expression, also contributed to the observed effects of CSE on aneurysm pathogenesis.
Immune cells and inflammatory markers have been found to be systemically increased in cigarette smokers. [33] [34] [35] Studies in cell culture and animal models have demonstrated increased immune modulating cells and cytokines after CSE. [27] [28] [29] [30] [31] [32] In the present study, CSE resulted in a proinflammatory, matrix remodeling phenotype in a NOX-dependent fashion. Both in vivo and in vitro CSE resulted in downregulation of myocardin, SM-α-actin, SM-MHC, and SM-22α and upregulation of MCP-1, MMPs, TNF-α, IL-1β, and NF-κB. These alterations have been found to be critical steps in the initiation of atherosclerosis, vascular disease, and CA pathogenesis. We previously found that TNF-α expression is increased in CA formation and rupture and that genetic and pharmacological inhibitions of TNF-α decrease formation and rupture of CAs. ROS have been shown to activate TNF-α which, as an immune modulator, can activate further proinflammatory cascades in macrophages and phenotypic modulation in VSMCs. MCP-1 has been found to be increased in CA walls, and genetic inhibition of MCP-1 decreases MMP production and the incidence of CA formation. This may work through a variety of mechanisms, including chemoattraction of macrophages into CAs leading to further production of ROS, TNF-α, and MMPs. 53 MMPs degrade the extracellular matrix 54 and have been found to be increased in human CAs. 55 Inhibition of MMPs has also been shown to decrease the incidence of CA formation and progression in animals. 46, 56 NF-κB has also been shown to help produce ROS, and prior studies have demonstrated that it is necessary for CA formation. In addition, IL-1β promotes SMC phenotypic modulation through increased expression of proinflammatory genes and has been found to be a key mediator of atherosclerosis and vascular injury.
It currently remains unclear whether CA rupture is the end result of CA formation, or whether molecular mediators are activated after CA formation and are required for CA progression and eventual rupture. In the current study, CSE-initiated oxidative stress induced VSMC phenotypic modulation leading to both CA formation and rupture.
Oxidative stress can result from increased production and decreased removal of free radicals and can result in DNA damage, cellular toxicity, and apoptosis. 57 Other key inflammatory mediators, such as TNF-α, help regulate apoptosis and phagocytosis of VSMCs and may lead to CA progression and rupture. 43, [58] [59] [60] After exposure to CSE, VSMCs change from a contractile phenotype to one characterized by proinflammatory characteristics and matrix remodeling, which may eventually lead to apoptosis, with loss of both phenotypes and eventual CA rupture.
Further assessment of the molecular mechanisms underlying both CA formation and progression is indicated. We have previously found that epigenetic control mechanisms, including alterations in histone modifications characteristic of transcriptional suppression, [61] [62] [63] provided evidence that KLF4 regulates cerebral VSMC phenotypic modulation through inhibition of myocardin-mediated activation of SMC genes. 41, 64 KLF4 is a pluripotency factor involved in the reprogramming of somatic cells. 65 Prior studies have also shown that KLF4 is required for SMC phenotypic modulation after vascular injury 41 and experimental atherosclerosis. 42 The SMC-MHC gene 39 and myocardin promoter 38 also possess KLF4-binding sites and are inhibited during SMC phenotypic switching to an inflammatory phenotype. KLF4 has also been found to be integral to the activation of macrophages, an inflammatory cell necessary for CA formation. 53, 66 In the present study, KLF4 was increased, and myocardin was decreased after CSE, but after NOX1 upregulation and formation of ROS.
Although oxidative stress and VSMC phenotypic modulation are likely key elements for CA pathogenesis, it is probably a multifactorial process that leads to CA pathogenesis. In this study, we focused on the effects of CSE on VSM phenotypic modulation, a characteristic of aneurysm pathophysiology, and on CA pathogenesis. However, CSE would have a global effect on the cellular vascular environment, affecting not only VSM but also endothelial cell, and infiltrating macrophages which would all culminate in CA formation, progression, and rupture. Interestingly, CSE increases intracellular communication between VSM, and endothelial cells, and macrophages leading to altered modulation of signaling molecules associated with abdominal aortic aneurysm formation. 67 The ability of CSE to induce endothelial dysfunction in cerebral arteries is well documented. 68 Therefore, it is likely that the CSE-induced aneurysm formation and rupture observed in this study are the results of the accumulative effects of VSM, endothelial cells, and macrophages dysfunction by CSE.
In conclusion, this is the first study to assess how CSE induces oxidative stress and cerebral VSMC phenotypic modulation in CA pathogenesis. It provides novel in vitro and in vivo evidence that CSE profoundly suppresses expression of mature cerebral VSMC marker genes and promotes matrix remodeling/inflammatory gene expression in CA formation and rupture. These processes are, at least in part, regulated by CSE induction of NOX1-associated oxidative stress. This provides important mechanisms, whereby CSE may contribute to CA pathogenesis and provide pathways for protective therapies.
